Pancreatic cancer researcher will focus on development of targeted therapeutics
Nov. 20, 2018
| By Sabrina Richards / Fred Hutch News Service
Fred Hutchinson Cancer Research Center pancreatic cancer researcher Dr. Sita Kugel has been named a 2018 V Scholar by the V Foundation for Cancer Research. The two-year, $200,000 award will support Kugel’s goal of developing a targeted therapy for an aggressive subtype of pancreatic cancer.
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Nov. 16, 2018
| By Sabin Russell / Fred Hutch News Service
Fred Hutch is about to lead a clinical trial offering cord blood transplants to blood cancer patients who also have HIV. The tranplants will carry a genetic trait that naturally confers resistance to HIV, so there is a possibility these transplants might also cure their HIV.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.